Adicet Bio ACET
NASDAQ ACET
$4.28 -0.21 (-4.68%)
At close: Oct 22, 2026 · 4:00 PM EDT

Adicet Bio (ACET) Non-Current Deferred Tax Liability (2020 - 2021)

Updated

Adicet Bio's Non-Current Deferred Tax Liability was $77,000 in Q1 2021, down 38.4% from the prior quarter.

Analysis

Adicet Bio (ACET) Non-Current Deferred Tax Liability (2020 - 2021) Analysis & Trends

At the end of FY2020, Non-Current Deferred Tax Liability at Adicet Bio came in at $125,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Adicet Bio 45.67 Mn -471.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 77,000.00
Dec 31, 2020 125,000.00
Sep 30, 2020 367,000.00
API Access

Adicet Bio Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ACET&period=max&api_key=YOUR_API_KEY